Product Information
LUBIPROSTONE 24 MCG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.6239 per EA under NDC 70710164206. Its NADAC has been published 140 times since Dec 20, 2023.
FDA first approved this application on Mar 23, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
24 ug/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710164206
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LUBIPROSTONEApproval Type
Generic (ANDA)
FDA Application
ANDA214131FDA Approved
3/23/2023
TE Code
AB
On Market Since
3/23/2023
Pharmacological Classes
Price Statistics
The NADAC for LUBIPROSTONE 24 MCG CAPSULE has been published 140 times since Dec 20, 2023, and over the history we have for it it has declined 49.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6239 per EA |
|---|---|
| All-time high | $1.2408 (Jan 10, 2024) |
| All-time low | $0.5868 (Nov 20, 2024) |
| 52-week high | $0.8250 |
| 52-week low | $0.6239 |
| Median price | $0.8082 |
| Average price | $0.8018 |
| Largest weekly change | +36.3% (Dec 11, 2024) |
| Weeks tracked | 140 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LUBIPROSTONE 24 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 24 MCG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.6239 per EA (NDC 70710164206), effective Aug 19, 2026.
How has the price of LUBIPROSTONE 24 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for LUBIPROSTONE 24 MCG CAPSULE has declined 49.7%. It has been tracked across 140 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 24 MCG CAPSULE?
Since Dec 20, 2023, the NADAC for LUBIPROSTONE 24 MCG CAPSULE has ranged from a low of $0.5868 (Nov 20, 2024) to a high of $1.2408 (Jan 10, 2024), with a median of $0.8082 per EA.
Are there cheaper alternatives to LUBIPROSTONE 24 MCG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LUBIPROSTONE 24 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LUBIPROSTONE 24 MCG CAPSULE?
LUBIPROSTONE 24 MCG CAPSULE (NDC 70710164206) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.